Stocks and Investing
Stocks and Investing
Thu, March 16, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Joseph Stringer Reiterated (STOK) at Strong Buy and Held Target at $25 on, Mar 16th, 2023
Joseph Stringer of Needham, Reiterated "Stoke Therapeutics, Inc." (STOK) at Strong Buy and Held Target at $25 on, Mar 16th, 2023.
Joseph has made no other calls on STOK in the last 4 months.
There are 4 other peers that have a rating on STOK. Out of the 4 peers that are also analyzing STOK, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Joseph
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Tuesday, March 7th, 2023
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $20 on, Tuesday, March 7th, 2023
- Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $28 on, Tuesday, March 7th, 2023
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, March 7th, 2023
Contributing Sources